Genomics-based drug discovery offers great potential for the development of targeted therapies that can offer new and better treatment options for patients. By ...
Continue reading
In precision medicine trials, DNA sequencing is not a background step. It determines eligibility, shapes enrollment pathways, and directly influences the qualit...
Continue reading
This webinar, hosted by Sano Genetics Partnership Lead Lindsey Wahlstrom-Edwards and featuring representatives from COUCH Health, Lupus Research Alliance, and A...
Continue reading
In this episode of "The Genetics Podcast," host Patrick Short interviews Daniel McArthur, Director of the Centre for Population Genomics at the Garvan Institute...
Continue reading
National DNA Day, observed on April 25th, commemorates the discovery of the double helix structure of DNA. It’s an annual, global celebration – and this year, i...
Continue reading
Precision medicine represents a fundamental shift in how therapies are developed and delivered. Rather than designing treatments for the average patient, it tak...
Continue reading
This webinar, hosted by Patrick Short, CEO of Sano Genetics, and featuring Dr. Mark Kotter, CEO of bit.bio, focused on precision medicine in multiple sclerosis....
Continue reading
This webinar was hosted by Sano Genetics' scientific advisor, Paul Wicks, and featured representatives from Genomics England as well as Sage Bionetworks. The di...
Continue reading
Sano raises $11 million in Series A funding round led by MMC Ventures New funding will support the team to grow and further its mission to accelerate personalis...
Continue reading
If you missed our webinar, you can catch up on an exciting discussion about the future of precision medicine research in multiple sclerosis here on our blog.
Continue reading